A Study of PTC923 in Participants With Phenylketonuria
Study sponsor: PTC Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-04-03Actual
Enrollment · participants157Actual
Source updated2024-01-10Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.